Physician
New Orleans Physician Services INC
New Orleans Physician Services INC was paid $23.51M by Medicaid between Jan 2018 and Dec 2024, across 183 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 16% of everything it billed.
33Billing provider infoNEW ORLEANS PHYSICIAN SERVICES INC
MARRERO, LA 70072
MARRERO, LA 70072
33aNPI1396169678assigned 02/07/2014
33bProvider typeEmergency Medicine Physician
28Total paid$23.51M
24GClaims1,888,091
24DCodes billed183
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Emergency Medicine Physician providers in Louisiana
Rank by total paid#2 of 101
Median peer was paid$227K
This provider vs. median104×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 123,294 | $1.65M | |
| 2019 | 105,872 | $1.80M | |
| 2020 | 223,437 | $3.22M | |
| 2021 | 268,194 | $4.17M | |
| 2022 | 290,093 | $4.63M | |
| 2023 | 418,503 | $4.75M | |
| 2024incomplete | 458,698 | $3.31M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 16% | 100,472 | 90,008 | $3.81M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 16% | 47,086 | 40,731 | $3.74M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 12% | 45,460 | 40,462 | $2.77M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 10% | 76,495 | 65,543 | $2.40M |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 5.7% | 34,967 | 12,781 | $1.35M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 3.2% | 22,799 | 20,299 | $751K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 3.2% | 11,269 | 9,996 | $741K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2.8% | 30,928 | 21,053 | $659K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2.8% | 30,938 | 21,061 | $658K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 2.6% | 13,718 | 12,588 | $617K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 1.9% | 7,931 | 7,038 | $455K |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 1.7% | 15,958 | 6,316 | $389K |
171 more codes
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 1.6% | 16,208 | $368K |
| 99223 | Prolong inpt eval add15 m | 1.5% | 4,814 | $364K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.4% | 14,392 | $322K |
| 81514 | 1.3% | 2,726 | $314K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 1.1% | 3,051 | $254K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 58,551 | $232K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 4,858 | $212K |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 5,252 | $208K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 15,007 | $192K |
| 86803 | <1% | 16,170 | $133K | |
| 99220 | <1% | 2,179 | $125K | |
| 86780 | <1% | 16,140 | $122K | |
| 87510 | <1% | 11,712 | $119K | |
| 87480 | <1% | 11,713 | $119K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 2,565 | $113K |
| 87660 | <1% | 9,330 | $106K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 1,854 | $104K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 723 | $98K |
| 87340 | <1% | 16,217 | $97K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 1,929 | $87K |
| 59409 | Vaginal delivery only (with or without episiotomy and/or forceps) | <1% | 134 | $79K |
| 87481 | <1% | 5,749 | $76K | |
| 87511 | <1% | 5,717 | $75K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 917 | $75K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 5,504 | $73K |
| 81025 | <1% | 17,683 | $64K | |
| 76830 | Ultrasound, transvaginal | <1% | 1,608 | $63K |
| 95811 | <1% | 372 | $61K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 1,892 | $60K |
| 95806 | <1% | 1,453 | $59K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 11,563 | $57K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 1,009 | $56K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 3,888 | $44K |
| 93016 | <1% | 3,535 | $39K | |
| 93356 | <1% | 1,871 | $36K | |
| 93880 | <1% | 1,216 | $31K | |
| 93000 | <1% | 4,075 | $30K | |
| 94729 | <1% | 2,844 | $29K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 319 | $28K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 687 | $27K |
| 94726 | <1% | 2,602 | $27K | |
| 93018 | <1% | 3,531 | $26K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 371 | $25K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 1,411 | $21K |
| 84702 | <1% | 2,573 | $20K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,030 | $16K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,319 | $16K |
| 86762 | <1% | 1,887 | $15K | |
| 99385 | <1% | 213 | $15K | |
| 90674 | <1% | 537 | $14K | |
| 84144 | <1% | 1,232 | $14K | |
| 93298 | <1% | 1,459 | $13K | |
| 87653 | <1% | 585 | $12K | |
| 94010 | <1% | 1,608 | $11K | |
| 81003 | <1% | 11,769 | $10K | |
| 93227 | <1% | 703 | $10K | |
| 99226 | <1% | 385 | $9K | |
| 59025 | Fetal non-stress test | <1% | 345 | $9K |
| 52000 | <1% | 106 | $9K | |
| 84146 | <1% | 654 | $8K | |
| 83001 | <1% | 679 | $8K | |
| 90678 | <1% | 60 | $6K | |
| 93015 | <1% | 141 | $6K | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 591 | $6K |
| 90715 | <1% | 176 | $5K | |
| 0002A | <1% | 140 | $5K | |
| 99464 | <1% | 115 | $5K | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 685 | $5K |
| 97803 | <1% | 315 | $5K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 128 | $4K |
| 99225 | <1% | 219 | $4K | |
| 82950 | <1% | 1,355 | $4K | |
| 99236 | Prolong inpt eval add15 m | <1% | 103 | $4K |
| 97802 | <1% | 250 | $4K | |
| 94060 | <1% | 370 | $4K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 449 | $3K |
| 95251 | <1% | 255 | $3K | |
| 0001A | <1% | 79 | $3K | |
| 93224 | <1% | 47 | $3K | |
| 43259 | <1% | 40 | $3K | |
| 81002 | <1% | 5,227 | $2K | |
| 87081 | <1% | 582 | $2K | |
| 76641 | <1% | 30 | $2K | |
| 51798 | <1% | 481 | $2K | |
| 90661 | <1% | 166 | $2K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 36 | $2K |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | <1% | 32 | $2K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 50 | $2K |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 13 | $2K |
| 94727 | <1% | 147 | $1K | |
| 93793 | <1% | 287 | $1K | |
| 76801 | <1% | 12 | $1K | |
| 99205 | Prolong outpt/office vis | <1% | 15 | $977.52 |
| 99234 | <1% | 18 | $809.04 | |
| 99442 | <1% | 70 | $737.00 | |
| 99219 | <1% | 12 | $722.00 | |
| 99459 | <1% | 48 | $662.40 | |
| 99221 | <1% | 18 | $626.88 | |
| 90682 | <1% | 21 | $504.09 | |
| 99235 | <1% | 17 | $491.58 | |
| 99441 | <1% | 39 | $392.37 | |
| 99307 | <1% | 64 | $328.68 | |
| 93308 | <1% | 16 | $304.35 | |
| 82270 | <1% | 115 | $258.40 | |
| 81001 | <1% | 384 | $225.58 | |
| 93244 | <1% | 13 | $155.17 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 107 | $150.50 |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 14 | $127.88 |
| 94618 | <1% | 33 | $118.32 | |
| 99358 | Prolong nursin fac eval 15m | <1% | 23 | $113.80 |
| 93299 | <1% | 13 | $68.80 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 1,259 | $37.21 |
| 3044F | <1% | 11,821 | $30.00 | |
| 3351F | <1% | 15,113 | $24.83 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 420 | $18.55 |
| 3008F | <1% | 101,612 | $15.45 | |
| 1036F | <1% | 54,908 | $8.43 | |
| 1159F | <1% | 108,376 | $4.62 | |
| 3075F | <1% | 17,042 | $3.98 | |
| 1158F | <1% | 35,922 | $3.24 | |
| 1101F | <1% | 57,272 | $1.67 | |
| 1160F | <1% | 105,320 | $0.89 | |
| 3074F | <1% | 71,603 | $0.31 | |
| 3078F | <1% | 67,170 | $0.27 | |
| 2000F | <1% | 54,948 | $0.21 | |
| 3079F | <1% | 32,870 | $0.09 | |
| 3080F | <1% | 4,634 | $0.03 | |
| 3077F | <1% | 10,780 | $0.03 | |
| 99499 | <1% | 18 | $0.01 | |
| 1125F | 0% | 33,337 | $0.00 | |
| 1170F | 0% | 80,685 | $0.00 | |
| 1220F | 0% | 53,664 | $0.00 | |
| 1034F | 0% | 4,767 | $0.00 | |
| 1126F | 0% | 67,060 | $0.00 | |
| 4010F | 0% | 17,593 | $0.00 | |
| 3048F | 0% | 5,147 | $0.00 | |
| 1031F | 0% | 20,813 | $0.00 | |
| G8952 | Elevated or hypertensive blood pressure reading documented, indicated follow-up not documented, reason not given | 0% | 69 | $0.00 |
| 4037F | 0% | 455 | $0.00 | |
| 4000F | 0% | 3,217 | $0.00 | |
| 3061F | 0% | 450 | $0.00 | |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | 0% | 680 | $0.00 |
| 0399T | 0% | 193 | $0.00 | |
| 1111F | 0% | 2,848 | $0.00 | |
| 3014F | 0% | 52 | $0.00 | |
| 3352F | 0% | 160 | $0.00 | |
| 3066F | 0% | 1,987 | $0.00 | |
| 3049F | 0% | 738 | $0.00 | |
| 1035F | 0% | 251 | $0.00 | |
| 3017F | 0% | 149 | $0.00 | |
| 4450F | 0% | 26 | $0.00 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 0% | 15 | $0.00 |
| 99000 | 0% | 15 | $0.00 | |
| 1123F | 0% | 16 | $0.00 | |
| 2001F | 0% | 22 | $0.00 | |
| 99450 | 0% | 24 | $0.00 | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 0% | 16 | $0.00 |
| 1033F | 0% | 30,773 | $0.00 | |
| 4004F | 0% | 14,283 | $0.00 | |
| 3288F | 0% | 15,566 | $0.00 | |
| 1090F | 0% | 2,419 | $0.00 | |
| 1032F | 0% | 2,224 | $0.00 | |
| G9744 | Patient not eligible due to active diagnosis of hypertension | 0% | 977 | $0.00 |
| 3062F | 0% | 69 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 325 | $0.00 |
| 3050F | 0% | 353 | $0.00 | |
| 1026F | 0% | 83 | $0.00 | |
| 91300 | 0% | 218 | $0.00 | |
| G2010 | Remote evaluation of recorded video and/or images submitted by an established patient (e.g., store and forward), including interpretation with follow-up with the patient within 24 business hours, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment | 0% | 82 | $0.00 |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | 0% | 70 | $0.00 |
| 3046F | 0% | 44 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMATHERNE, KANDACE (CREDENTIALING SPECIALIST)